Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib vs Imatinib vs Supportive Care in COVID-19 Pneumonia
NCT04346147Phase 2Unknown
- Sponsor
- Hospital Universitario de Fuenlabrada
- Start
- May 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib, imatinib in COVID-19 pneumonia, sponsored by Hospital Universitario de Fuenlabrada. Status: unknown.
02
Drugs
baricitinibimatinib
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04346147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04346147.